Share on StockTwits

Cardinal Health (NYSE:CAH) CFO Jeffrey William Henderson sold 78,637 shares of the company’s stock in a transaction dated Monday, August 18th. The shares were sold at an average price of $72.06, for a total transaction of $5,666,582.22. Following the completion of the transaction, the chief financial officer now directly owns 67,190 shares in the company, valued at approximately $4,841,711. The transaction was disclosed in a filing with the SEC, which is available at this link.

Cardinal Health (NYSE:CAH) traded up 1.20% on Thursday, hitting $73.35. 882,380 shares of the company’s stock traded hands. Cardinal Health has a 52 week low of $49.65 and a 52 week high of $74.40. The stock has a 50-day moving average of $71.18 and a 200-day moving average of $69.61. The company has a market cap of $24.694 billion and a P/E ratio of 21.45.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Monday, August 4th. The company reported $0.83 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.81 by $0.02. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $21.88 billion. During the same quarter last year, the company posted $0.79 earnings per share. Cardinal Health’s revenue was down 9.9% compared to the same quarter last year. On average, analysts predict that Cardinal Health will post $4.25 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a dividend of $0.3425 per share. This represents a $1.37 annualized dividend and a dividend yield of 1.89%. The ex-dividend date is Monday, September 29th.

A number of analysts have recently weighed in on CAH shares. Analysts at Argus reiterated a “buy” rating on shares of Cardinal Health in a research note on Monday. They now have a $71.43 price target on the stock, down previously from $83.00. Separately, analysts at Barclays reiterated an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $82.00 price target on the stock, up previously from $77.00. Finally, analysts at Credit Suisse reiterated an “outperform” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $80.00 price target on the stock, up previously from $76.00. Three investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Cardinal Health presently has a consensus rating of “Buy” and a consensus price target of $77.93.

Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.